Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action inhibitors, antagonists |
Mechanism CD8 inhibitors(Cluster of differentiation 8 inhibitors), TLR9 antagonists(Toll like receptor 9 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuromuscular Diseases | Preclinical | United States | 16 May 2025 |